Avillion
Avillion/Merck psoriasis nanobody hits the mark in phase 2
Phil Taylor
Avillion, dermatology, Immunology and inflammation, Merck KGaA, nanobody, psoriasis
0 Comment
X
Avillion/Merck psoriasis nanobody hits the mark in phase 2
https://pharmaphorum.com/news/avillion-merck-psoriasis-nanobody-hits-the-mark-in-phase-2/